Ika M - Search Results

1

Impact of IL28B polymorphisms on 24-week telaprevir-based combination therapy for Asian chronic hepatitis C patients with hepatitis C virus genotype 1b.

Tsubota A, Shimada N, Atsukawa M, Abe H, Kato K, Ika M, Matsudaira H, Nagatsuma K, Matsuura T, Aizawa Y. Tsubota A, et al. Among authors: ika m. J Gastroenterol Hepatol. 2014 Jan;29(1):144-50. doi: 10.1111/jgh.12402. J Gastroenterol Hepatol. 2014. PMID: 24117654

2

Contribution of ribavirin transporter gene polymorphism to treatment response in peginterferon plus ribavirin therapy for HCV genotype 1b patients.

Tsubota A, Shimada N, Yoshizawa K, Furihata T, Agata R, Yumoto Y, Abe H, Ika M, Namiki Y, Chiba K, Fujise K, Tada N, Aizawa Y. Tsubota A, et al. Among authors: ika m. Liver Int. 2012 May;32(5):826-36. doi: 10.1111/j.1478-3231.2011.02727.x. Epub 2011 Dec 30. Liver Int. 2012. PMID: 22212648 Clinical Trial.

3

Several factors including ITPA polymorphism influence ribavirin-induced anemia in chronic hepatitis C.

Tsubota A, Shimada N, Abe H, Yoshizawa K, Agata R, Yumoto Y, Ika M, Namiki Y, Nagatsuma K, Matsudaira H, Fujise K, Tada N, Aizawa Y. Tsubota A, et al. Among authors: ika m. World J Gastroenterol. 2012 Nov 7;18(41):5879-88. doi: 10.3748/wjg.v18.i41.5879. World J Gastroenterol. 2012. PMID: 23139603 Free PMC article. Clinical Trial.

4

New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection.

Abe H, Aida Y, Ishiguro H, Yoshizawa K, Seki N, Miyazaki T, Itagaki M, Sutoh S, Ika M, Kato K, Shimada N, Tsubota A, Aizawa Y. Abe H, et al. Among authors: ika m. J Med Virol. 2013 Sep;85(9):1523-33. doi: 10.1002/jmv.23626. Epub 2013 Jun 17. J Med Virol. 2013. PMID: 23775277

5

Serum apolipoprotein B-100 concentration predicts the virological response to pegylated interferon plus ribavirin combination therapy in patients infected with chronic hepatitis C virus genotype 1b.

Yoshizawa K, Abe H, Aida Y, Ishiguro H, Ika M, Shimada N, Tsubota A, Aizawa Y. Yoshizawa K, et al. Among authors: ika m. J Med Virol. 2013 Jul;85(7):1180-90. doi: 10.1002/jmv.23597. J Med Virol. 2013. PMID: 23918536

6

Serum lipoprotein profiles and response to pegylated interferon plus ribavirin combination therapy in patients with chronic HCV genotype 1b infection.

Aizawa Y, Shimada N, Abe H, Seki N, Aida Y, Ishiguro H, Ika M, Kato K, Tsubota A. Aizawa Y, et al. Among authors: ika m. Hepat Mon. 2013 May 27;13(5):e8988. doi: 10.5812/hepatmon.8988. eCollection 2013 May. Hepat Mon. 2013. PMID: 23967025 Free PMC article.

7

α-Fetoprotein is a surrogate marker for predicting treatment failure in telaprevir-based triple combination therapy for genotype 1b chronic hepatitis C Japanese patients with the IL28B minor genotype.

Shimada N, Tsubota A, Atsukawa M, Abe H, Ika M, Kato K, Sato Y, Kondo C, Sakamoto C, Tanaka Y, Aizawa Y. Shimada N, et al. Among authors: ika m. J Med Virol. 2014 Mar;86(3):461-72. doi: 10.1002/jmv.23824. Epub 2013 Oct 28. J Med Virol. 2014. PMID: 24166425

8

A 48-week telaprevir-based triple combination therapy improves sustained virological response rate in previous non-responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study.

Shimada N, Tsubota A, Atsukawa M, Abe H, Ide T, Takaguchi K, Chuganji Y, Toyoda H, Yoshizawa K, Ika M, Sato Y, Kato K, Kumada T, Sakamoto C, Aizawa Y, Sata M. Shimada N, et al. Among authors: ika m. Hepatol Res. 2014 Dec;44(14):E386-96. doi: 10.1111/hepr.12323. Epub 2014 Apr 15. Hepatol Res. 2014. PMID: 24606109

9

Hepatocellular adenoma in a woman who was undergoing testosterone treatment for gender identity disorder.

Kato K, Abe H, Hanawa N, Fukuzawa J, Matsuo R, Yonezawa T, Itoh S, Sato Y, Ika M, Shimizu S, Endo S, Hano H, Izu A, Sugitani M, Tsubota A. Kato K, et al. Among authors: ika m. Clin J Gastroenterol. 2018 Oct;11(5):401-410. doi: 10.1007/s12328-018-0854-4. Epub 2018 Mar 27. Clin J Gastroenterol. 2018. PMID: 29589251

10

C-Arm Cone Beam Computed Tomography Guidance for Radiofrequency Ablation in Hepatocellular Carcinoma.

Kato K, Abe H, Ika M, Yonezawa T, Sato Y, Hanawa N, Shimizu S, Endo S, Matsuo R, Tsubota A. Kato K, et al. Among authors: ika m. Oncology. 2017;92(3):142-152. doi: 10.1159/000453665. Epub 2017 Jan 5. Oncology. 2017. PMID: 28052301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters